234 related articles for article (PubMed ID: 32946865)
41. Epithelial cell-derived micro RNA-146a generates interleukin-10-producing monocytes to inhibit nasal allergy.
Luo X; Han M; Liu J; Wang Y; Luo X; Zheng J; Wang S; Liu Z; Liu D; Yang PC; Li H
Sci Rep; 2015 Nov; 5():15937. PubMed ID: 26526003
[TBL] [Abstract][Full Text] [Related]
42. Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3.
Deng YQ; Yang YQ; Wang SB; Li F; Liu MZ; Hua QQ; Tao ZZ
PLoS One; 2015; 10(9):e0139322. PubMed ID: 26418311
[TBL] [Abstract][Full Text] [Related]
43. Role of miR-146a in Enforcing Effect of Specific Immunotherapy on Allergic Rhinitis.
Liu HJ; Zhang AF; Zhao N; Li XZ
Immunol Invest; 2016; 45(1):1-10. PubMed ID: 26700406
[TBL] [Abstract][Full Text] [Related]
44. Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis.
Liu Z; Yang X; Liu X; Mu Y; Wang L; Song X; Zhang H
J Infect Public Health; 2021 Jan; 14(1):77-83. PubMed ID: 31753724
[TBL] [Abstract][Full Text] [Related]
45. Neuromedin U Induces Activation of Peripheral Group 2 Innate Lymphoid Cells through the ERK Pathway in Allergic Rhinitis Patients.
Qi X; Zhuo H; Wang Y; Ren F; Xue J; An Y; Zhao C
Int Arch Allergy Immunol; 2023; 184(1):1-11. PubMed ID: 36244335
[TBL] [Abstract][Full Text] [Related]
46. Prevention of allergic rhinitis by aldose reductase inhibition in a murine model.
Yadav UC; Mishra R; Aguilera-Aguirre L; Sur S; Bolodgh I; Ramana KV; Srivatsava SK
Inflamm Allergy Drug Targets; 2013 Jun; 12(3):178-86. PubMed ID: 23360251
[TBL] [Abstract][Full Text] [Related]
47. Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis.
Zhong H; Fan XL; Yu QN; Qin ZL; Chen D; Xu R; Chen DH; Lin ZB; Wen W; Fu QL
Clin Immunol; 2017 Oct; 183():293-299. PubMed ID: 28917723
[TBL] [Abstract][Full Text] [Related]
48. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis.
Steelant B; Seys SF; Van Gerven L; Van Woensel M; Farré R; Wawrzyniak P; Kortekaas Krohn I; Bullens DM; Talavera K; Raap U; Boon L; Akdis CA; Boeckxstaens G; Ceuppens JL; Hellings PW
J Allergy Clin Immunol; 2018 Mar; 141(3):951-963.e8. PubMed ID: 29074456
[TBL] [Abstract][Full Text] [Related]
49. An essential role for dendritic cells in human and experimental allergic rhinitis.
KleinJan A; Willart M; van Rijt LS; Braunstahl GJ; Leman K; Jung S; Hoogsteden HC; Lambrecht BN
J Allergy Clin Immunol; 2006 Nov; 118(5):1117-25. PubMed ID: 17088138
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-466a-3p attenuates allergic nasal inflammation in mice by targeting GATA3.
Chen Z; Deng Y; Li F; Xiao B; Zhou X; Tao Z
Clin Exp Immunol; 2019 Sep; 197(3):366-375. PubMed ID: 31081939
[TBL] [Abstract][Full Text] [Related]
51. H2-Eb1 expression is upregulated in the nasal mucosa of allergic rhinitis.
Zhang Y; Feng J; Sun J; Wang H; Zhang C; Liu H; Zhang H
Asian Pac J Allergy Immunol; 2014 Dec; 32(4):308-15. PubMed ID: 25543041
[TBL] [Abstract][Full Text] [Related]
52. Intranasal immunization with phosphorylcholine suppresses allergic rhinitis in mice.
Miyashita K; Ohori J; Nagano H; Fukuyama S; Kurono Y
Laryngoscope; 2018 Jul; 128(7):E234-E240. PubMed ID: 29193138
[TBL] [Abstract][Full Text] [Related]
53. [The Orai1 antibody treatment for a mouse model of allergic rhinitis].
Lin L; Dai F; Sun T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 51(1):43-9. PubMed ID: 26791768
[TBL] [Abstract][Full Text] [Related]
54. The role of hypoxia-inducible factor 1α in allergic rhinitis.
Mo JH; Kim JH; Lim DJ; Kim EH
Am J Rhinol Allergy; 2014; 28(2):e100-6. PubMed ID: 24717944
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of MicroRNA-21 by an antagomir ameliorates allergic inflammation in a mouse model of asthma.
Lee HY; Lee HY; Choi JY; Hur J; Kim IK; Kim YK; Kang JY; Lee SY
Exp Lung Res; 2017 Apr; 43(3):109-119. PubMed ID: 28379062
[TBL] [Abstract][Full Text] [Related]
56. c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells.
Trabanelli S; Ercolano G; Wyss T; Gomez-Cadena A; Falquet M; Cropp D; Imbratta C; Leblond MM; Salvestrini V; Curti A; Adotevi O; Jandus C; Verdeil G
EMBO J; 2022 Jun; 41(12):e109300. PubMed ID: 35467036
[TBL] [Abstract][Full Text] [Related]
57. Regulatory effects of miRNA-126 on Th cell differentiation and cytokine expression in allergic rhinitis.
Jia H; Zhang R; Liang X; Jiang X; Bu Q
Cell Signal; 2022 Nov; 99():110435. PubMed ID: 35953026
[TBL] [Abstract][Full Text] [Related]
58. [Expression and significance of Notch1-Jagged1 in allergic rhinitis].
Jiao WE; Wei JF; Xu S; Kong YG; Xu Y; Tao ZZ; Chen SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Oct; 53(10):733-739. PubMed ID: 30347531
[No Abstract] [Full Text] [Related]
59. The environmental hormone nonylphenol interferes with the therapeutic effects of G protein-coupled estrogen receptor specific agonist G-1 on murine allergic rhinitis.
Wang YX; Gu ZW; Hao LY
Int Immunopharmacol; 2020 Jan; 78():106058. PubMed ID: 31835084
[TBL] [Abstract][Full Text] [Related]
60. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
Jin J; Sunusi S; Lu H
J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
